Keuhkoverenkiertohäiriö

Keuhkoverenkiertohäiriö refers to a group of conditions affecting the blood vessels within the lungs. The primary function of the pulmonary circulation is to transport deoxygenated blood from the right side of the heart to the lungs for oxygenation and then return the oxygenated blood to the left side of the heart. Disruptions in this system can lead to various problems.

One common type of keuhkoverenkiertohäiriö is pulmonary hypertension, which is characterized by high blood pressure in the pulmonary arteries. This can be caused by several factors, including left heart disease, lung diseases like COPD or interstitial lung disease, blood clots in the lungs (pulmonary embolism), or congenital heart defects. Pulmonary hypertension can lead to the right ventricle of the heart to enlarge and weaken as it struggles to pump blood against the increased resistance.

Another significant keuhkoverenkiertohäiriö is pulmonary embolism, where a blood clot travels to the lungs and blocks one or more pulmonary arteries. This can cause sudden shortness of breath, chest pain, and rapid heart rate. Pulmonary embolism is a potentially life-threatening condition that requires prompt medical attention.

Symptoms of keuhkoverenkiertohäiriö can vary depending on the specific condition and its severity, but often include shortness of breath, especially during exertion, fatigue, swelling in the legs and ankles, dizziness, and chest pain. Diagnosis typically involves a combination of physical examination, imaging tests such as chest X-rays and CT scans, echocardiograms to assess heart function, and sometimes specialized tests like a right heart catheterization.

Treatment approaches for keuhkoverenkiertohäiriö aim to manage symptoms, improve blood flow, and address the underlying cause. This can include medications to lower blood pressure, blood thinners to prevent clots, oxygen therapy, and in some cases, surgical interventions or lung transplantation. Early diagnosis and appropriate management are crucial for improving outcomes and quality of life for individuals affected by these circulatory disorders.